Zinc supplementation for patients with acute myocardial infarctio
Not Applicable
- Conditions
- Acute myocardial infarction
- Registration Number
- JPRN-UMIN000030232
- Lead Sponsor
- Showa University Northern Yokohama Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Hepatic cirrhosis (2)Dialysis (3)Inflammatory bowel disease (4)Chronic pancreatitis (5)After enterectomy or pancreaticoduodenectomy (6)Systemic inflammatory disease (7)Sickle cell anemia (8)Asthma, allergy of Gadolinium, MRI-none compatible pacemaker implanted (9)allergy of Zinc acetate (10) Patients with CTO in non-infarct related artery
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ength of stay in the coronary care unit Length of hospitalization stay Infarct size, LVEF evaluated by MRI
- Secondary Outcome Measures
Name Time Method The rate of requiring specific ancillary devices such as a temporary pacemaker, intra-aortic balloon pump (IABP), invasive and non-invasive positive pressure ventilation or venoarterial extracorporeal membrane oxygenation (VA-ECMO) LVEF, serum CK, CK-MB,BNP level all-cause and cardiovascular mortality